289 related articles for article (PubMed ID: 24827533)
1. Development of EULAR recommendations for the reporting of clinical trial extension studies in rheumatology.
Buch MH; Silva-Fernandez L; Carmona L; Aletaha D; Christensen R; Combe B; Emery P; Ferraccioli G; Guillemin F; Kvien TK; Landewe R; Pavelka K; Saag K; Smolen JS; Symmons D; van der Heijde D; Welling J; Wells G; Westhovens R; Zink A; Boers M;
Ann Rheum Dis; 2015 Jun; 74(6):963-9. PubMed ID: 24827533
[TBL] [Abstract][Full Text] [Related]
2. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. EULAR definition of difficult-to-treat rheumatoid arthritis.
Nagy G; Roodenrijs NMT; Welsing PM; Kedves M; Hamar A; van der Goes MC; Kent A; Bakkers M; Blaas E; Senolt L; Szekanecz Z; Choy E; Dougados M; Jacobs JW; Geenen R; Bijlsma HW; Zink A; Aletaha D; Schoneveld L; van Riel P; Gutermann L; Prior Y; Nikiphorou E; Ferraccioli G; Schett G; Hyrich KL; Mueller-Ladner U; Buch MH; McInnes IB; van der Heijde D; van Laar JM
Ann Rheum Dis; 2021 Jan; 80(1):31-35. PubMed ID: 33004335
[TBL] [Abstract][Full Text] [Related]
5. EULAR recommendations for a core data set for pregnancy registries in rheumatology.
Meissner Y; Fischer-Betz R; Andreoli L; Costedoat-Chalumeau N; De Cock D; Dolhain RJEM; Forger F; Goll D; Molto A; Nelson-Piercy C; Özdemir R; Raio L; Rodríguez-García SC; Sciascia S; Wallenius M; Zbinden A; Zink A; Strangfeld A
Ann Rheum Dis; 2021 Jan; 80(1):49-56. PubMed ID: 33055080
[TBL] [Abstract][Full Text] [Related]
6. EULAR points to consider when analysing and reporting comparative effectiveness research using observational data in rheumatology.
Courvoisier DS; Lauper K; Kedra J; de Wit M; Fautrel B; Frisell T; Hyrich KL; Iannone F; Machado PM; Ørnbjerg LM; Rotar Z; Santos MJ; Stamm TA; Stones SR; Strangfeld A; Bergstra SA; Landewé RBM; Finckh A
Ann Rheum Dis; 2022 Jun; 81(6):780-785. PubMed ID: 35058229
[TBL] [Abstract][Full Text] [Related]
7. German guidelines for the sequential medical treatment of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs.
Albrecht K; Krüger K; Wollenhaupt J; Alten R; Backhaus M; Baerwald C; Bolten W; Braun J; Burkhardt H; Burmester GR; Gaubitz M; Gause A; Gromnica-Ihle E; Kellner H; Kuipers J; Krause A; Lorenz HM; Manger B; Nüßlein H; Pott HG; Rubbert-Roth A; Schneider M; Specker C; Schulze-Koops H; Tony HP; Wassenberg S; Müller-Ladner U;
Rheumatol Int; 2014 Jan; 34(1):1-9. PubMed ID: 23942828
[TBL] [Abstract][Full Text] [Related]
8. 2014 Update of the EULAR standardised operating procedures for EULAR-endorsed recommendations.
van der Heijde D; Aletaha D; Carmona L; Edwards CJ; Kvien TK; Kouloumas M; Machado P; Oliver S; de Wit M; Dougados M
Ann Rheum Dis; 2015 Jan; 74(1):8-13. PubMed ID: 25261577
[TBL] [Abstract][Full Text] [Related]
9. European League Against Rheumatism (EULAR) Scleroderma Trial and Research group (EUSTAR) recommendations for the treatment of systemic sclerosis: methods of elaboration and results of systematic literature research.
Avouac J; Kowal-Bielecka O; Landewe R; Chwiesko S; Miniati I; Czirjak L; Clements P; Denton C; Farge D; Fligelstone K; Földvari I; Furst DE; Müller-Ladner U; Seibold J; Silver RM; Takehara K; Toth BG; Tyndall A; Valentini G; van den Hoogen F; Wigley F; Zulian F; Matucci-Cerinic M;
Ann Rheum Dis; 2009 May; 68(5):629-34. PubMed ID: 18957486
[TBL] [Abstract][Full Text] [Related]
10. Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations.
Aletaha D; Landewe R; Karonitsch T; Bathon J; Boers M; Bombardier C; Bombardieri S; Choi H; Combe B; Dougados M; Emery P; Gomez-Reino J; Keystone E; Koch G; Kvien TK; Martin-Mola E; Matucci-Cerinic M; Michaud K; O'Dell J; Paulus H; Pincus T; Richards P; Simon L; Siegel J; Smolen JS; Sokka T; Strand V; Tugwell P; van der Heijde D; van Riel P; Vlad S; van Vollenhoven R; Ward M; Weinblatt M; Wells G; White B; Wolfe F; Zhang B; Zink A; Felson D
Ann Rheum Dis; 2008 Oct; 67(10):1360-4. PubMed ID: 18791055
[TBL] [Abstract][Full Text] [Related]
11. Points to consider for cost-effective use of biological and targeted synthetic DMARDs in inflammatory rheumatic diseases: results from an umbrella review and international Delphi study.
van der Togt CJT; Van den Bemt B; Aletaha D; Alten R; Chatzidionysiou K; Galloway J; Isaac J; Mulleman D; Verschueren P; Vulto AG; Welsing PMJ; Verhoef L; den Broeder AA
RMD Open; 2023 Mar; 9(1):. PubMed ID: 36863753
[TBL] [Abstract][Full Text] [Related]
12. EULAR recommendations for the reporting of ultrasound studies in rheumatic and musculoskeletal diseases (RMDs).
Costantino F; Carmona L; Boers M; Backhaus M; Balint PV; Bruyn GA; Christensen R; Conaghan PG; Ferreira RJO; Garrido-Castro JL; Guillemin F; Hammer HB; van der Heijde D; Iagnocco A; Kortekaas MC; Landewé RB; Mandl P; Naredo E; Schmidt WA; Terslev L; Terwee CB; Thiele R; D'Agostino MA
Ann Rheum Dis; 2021 Jul; 80(7):840-847. PubMed ID: 33483318
[TBL] [Abstract][Full Text] [Related]
13. Practical help for specifying the target difference in sample size calculations for RCTs: the DELTA
Cook JA; Julious SA; Sones W; Hampson LV; Hewitt C; Berlin JA; Ashby D; Emsley R; Fergusson DA; Walters SJ; Wilson EC; MacLennan G; Stallard N; Rothwell JC; Bland M; Brown L; Ramsay CR; Cook A; Armstrong D; Altman D; Vale LD
Health Technol Assess; 2019 Oct; 23(60):1-88. PubMed ID: 31661431
[TBL] [Abstract][Full Text] [Related]
14. EULAR recommendations for the involvement of patient research partners in rheumatology research: 2023 update.
de Wit M; Aouad K; Elhai M; Benavent D; Bertheussen H; Blackburn S; Böhm P; Duarte C; Falahee M; Karlfeldt S; Kiltz U; Mateus EF; Richards DP; Rodríguez-Carrio J; Sagen J; Shumnalieva R; Stones SR; Tas SW; Tillett W; Vieira A; Wilhelmer TC; Zabalan C; Primdahl J; Studenic P; Gossec L
Ann Rheum Dis; 2024 Jun; ():. PubMed ID: 38876509
[TBL] [Abstract][Full Text] [Related]
15. European League Against Rheumatism recommendations for the inclusion of patient representatives in scientific projects.
de Wit MP; Berlo SE; Aanerud GJ; Aletaha D; Bijlsma JW; Croucher L; Da Silva JA; Glüsing B; Gossec L; Hewlett S; Jongkees M; Magnusson D; Scholte-Voshaar M; Richards P; Ziegler C; Abma TA
Ann Rheum Dis; 2011 May; 70(5):722-6. PubMed ID: 21257615
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological treatment (biotherapy excluded) of peripheral psoriatic arthritis: development of recommendations for clinical practice based on data from the literature and experts opinion.
Dernis E; Lavie F; Salliot C; Flipo RM; Saraux A; Maillefert JF; Paul C; Goupille P; Cantagrel A; Claudepierre P; Gaudin P; Tebib J; Wendling D; Schaeverbeke T; Le Loët X; Combe B
Joint Bone Spine; 2009 Oct; 76(5):524-31. PubMed ID: 19457691
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2013 update of the EULAR recommendations for the management of rheumatoid arthritis.
Nam JL; Ramiro S; Gaujoux-Viala C; Takase K; Leon-Garcia M; Emery P; Gossec L; Landewe R; Smolen JS; Buch MH
Ann Rheum Dis; 2014 Mar; 73(3):516-28. PubMed ID: 24399231
[TBL] [Abstract][Full Text] [Related]
18. 2018 update of the EULAR recommendations for the role of the nurse in the management of chronic inflammatory arthritis.
Bech B; Primdahl J; van Tubergen A; Voshaar M; Zangi HA; Barbosa L; Boström C; Boteva B; Carubbi F; Fayet F; Ferreira RJO; Hoeper K; Kocher A; Kukkurainen ML; Lion V; Minnock P; Moretti A; Ndosi M; Pavic Nikolic M; Schirmer M; Smucrova H; de la Torre-Aboki J; Waite-Jones J; van Eijk-Hustings Y
Ann Rheum Dis; 2020 Jan; 79(1):61-68. PubMed ID: 31300458
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritis.
Nam JL; Takase-Minegishi K; Ramiro S; Chatzidionysiou K; Smolen JS; van der Heijde D; Bijlsma JW; Burmester GR; Dougados M; Scholte-Voshaar M; van Vollenhoven R; Landewé R
Ann Rheum Dis; 2017 Jun; 76(6):1113-1136. PubMed ID: 28283512
[TBL] [Abstract][Full Text] [Related]
20. EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).
Combe B; Landewe R; Lukas C; Bolosiu HD; Breedveld F; Dougados M; Emery P; Ferraccioli G; Hazes JM; Klareskog L; Machold K; Martin-Mola E; Nielsen H; Silman A; Smolen J; Yazici H
Ann Rheum Dis; 2007 Jan; 66(1):34-45. PubMed ID: 16396980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
